[
  {
    "ts": null,
    "headline": "Why Humana Deserves Patience Now: Too Early to Buy, Too Risky to Sell",
    "summary": "HUM sits at a crossroads as Medicare Advantage pressures cap near-term upside, but resilience versus peers argues for patience, not panic.",
    "url": "https://finnhub.io/api/news?id=6f924fd61f207992a348db5d3bd76a093f6353f55139c4dd01c3d8bdca4fa02b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767107760,
      "headline": "Why Humana Deserves Patience Now: Too Early to Buy, Too Risky to Sell",
      "id": 137941943,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "HUM sits at a crossroads as Medicare Advantage pressures cap near-term upside, but resilience versus peers argues for patience, not panic.",
      "url": "https://finnhub.io/api/news?id=6f924fd61f207992a348db5d3bd76a093f6353f55139c4dd01c3d8bdca4fa02b"
    }
  }
]